BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li FS, Zhang YL, Li Z, Xu D, Liao CY, Ma H, Gong L, Su J, Sun Q, Xu Q, Gao Z, Wang L, Jing J, Wang J, Jiang M, Tian G, Hasan B. Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage. Exp Ther Med 2016;12:2477-88. [PMID: 27698749 DOI: 10.3892/etm.2016.3680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Yu XQ, Yang SG, Li H, Xie Y, Li JS, Zhang P. Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model. Evid Based Complement Alternat Med 2019;2019:6478926. [PMID: 31118965 DOI: 10.1155/2019/6478926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Li Z, Xu D, Jing J, Li F. Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment. Oncol Lett 2021;21:321. [PMID: 33692853 DOI: 10.3892/ol.2021.12583] [Reference Citation Analysis]
3 Xiong C, Li Y, Zhuang G, Zeng Y, Wei H, Li C, Li L, Liao L, Fu J. Clinical efficacy and safety of Chinese herbal medicine versus placebo for the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complement Ther Med 2021;59:102691. [PMID: 33618010 DOI: 10.1016/j.ctim.2021.102691] [Reference Citation Analysis]
4 Xiong C, Li Y, Zeng Y, Wei H, Zhuang GT, Li L, Zhao LH, Li CY, Qin EQ, Fu JJ. Chinese Herbal Medicine Versus Placebo for the Treatment Of Chronic Obstructive Pulmonary Disease: A Protocol of Systematic Review and Meta-analysis. Medicine (Baltimore) 2019;98:e17002. [PMID: 31464955 DOI: 10.1097/MD.0000000000017002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang XW, Liu W, Jiang HL, Mao B. Dissection of Pharmacological Mechanism of Chinese Herbal Medicine Yihuo Huatan Formula on Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study. Sci Rep 2019;9:13431. [PMID: 31530860 DOI: 10.1038/s41598-019-50064-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li M, Li Y, Li J, Zhao P, Bai Y, Feng S, Liu X, Wang Y, Bian Q, Li J. Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling. Evid Based Complement Alternat Med 2017;2017:2089027. [PMID: 29387126 DOI: 10.1155/2017/2089027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
7 Wang M, Gu W, Kui F, Gao F, Niu Y, Li W, Zhang Y, Guo L, Geng S, Du G. The Clinical Efficiency and the Mechanism of Sanzi Yangqin Decoction for Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med 2021;2021:5565562. [PMID: 34221077 DOI: 10.1155/2021/5565562] [Reference Citation Analysis]
8 Zhen G, Jing J, Dan X, Zheng L, Fengsen L, Qi S. A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome). Evid Based Complement Alternat Med 2017;2017:9130804. [PMID: 29348777 DOI: 10.1155/2017/9130804] [Reference Citation Analysis]